Emergent BioSolutions Inc. Annual Deferred Income Tax Expense (Benefit) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Emergent BioSolutions Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
  • Emergent BioSolutions Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was $1.9M.
  • Emergent BioSolutions Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$7.3M, a 78.3% increase from 2022.
  • Emergent BioSolutions Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$33.7M, a 178% decline from 2021.
  • Emergent BioSolutions Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $43M.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$7.3M +$26.4M +78.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 -$33.7M -$76.7M -178% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 $43M +$46.4M Jan 1, 2021 Dec 31, 2021 10-K 2024-03-08
2020 -$3.4M -$2.3M -209% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-12-11
2019 -$1.1M -$9.7M -113% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $8.6M +$5.3M +161% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
2017 $3.3M -$1.9M -36.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 $5.2M +$1.74M +50.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-22
2015 $3.46M -$13M -79% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-23
2014 $16.5M +$2.64M +19% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $13.9M +$10.5M +310% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $3.38M -$16.8M -83.2% Jan 1, 2012 Dec 31, 2012 10-K/A 2015-03-09
2011 $20.2M +$11M +119% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-10
2010 $9.23M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.